Disclosures for "COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD during the Omicron BA.1/2 wave in Singapore")
-
Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
-
Ms. Tye has nothing to disclose.
-
Ms. Peng has nothing to disclose.
-
Dr. Wong has nothing to disclose.
-
The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving as a Consultant for Edanz Pharma. The institution of Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Terumo BCT. The institution of Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Euroimmun AG . The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis . The institution of Dr. Yeo has received research support from National Medical Research Council (Singapore) . The institution of Dr. Yeo has received research support from Roche .